201. Abstracts of papers and posters presented at the 37th Annual SRIP Conference Principal Hotel, York, UK, 12th – 13th September 2017
- Author
-
Claire A. I. Stramrood, Miranda Olff, Jens Henrichs, and Anke B. Witteveen
- Subjects
Postpartum depression ,medicine.medical_specialty ,Epidemiological Factors ,business.industry ,Obstetrics and Gynecology ,medicine.disease ,behavioral disciplines and activities ,Clinical trial ,Mood ,Reproductive Medicine ,Oxytocin ,mental disorders ,Pediatrics, Perinatology and Child Health ,Epidemiology ,medicine ,Childbirth ,business ,Perinatal period ,General Psychology ,Clinical psychology ,medicine.drug - Abstract
Background: Traumatic birth experiences may give rise to PTSD following childbirth (PTSD-FC). The perinatal period is associated with neurobiological alterations in HPA axis- and oxytocinergic systems also implicated in the response to trauma. However, little is known about neurobiological alterations in PTSD-FC and how these may play a role in the prevention and treatment of PTSD-FC. Recent research indicates a potential role for oxytocin. Aim and Objectives: To provide a synthesis of evidence on epidemiology, prevention, and treatment of PTSD-FC including neurobiological alterations and treatment-potential of hormones such as oxytocin. Method: Literature searches were performed in PubMed, Psychinfo, and Web of Science. Results: The prevalence for PTSD-FC ranges from 3-4% in community samples to up to 19% in high risk samples. Clinical trials in the treatment or prevention of PTSD-FC are scarce and do not include neurobiological alterations but the related domains of PTSD and the perinatal period provide findings relevant for PTSD-FC. A systematic search for exogenous oxytocin trials in women with PTSD-FC generated no findings. However, direct neurobiological and psychological effects of oxytocin were positive in trials with PTSD patients albeit negative in trauma-exposed individuals. In postpartum women an oxytocin-related increase of neural processing in reward-related areas was found as well as improved therapist- and infant relationships in women with postpartum depression although their mood worsened. Interpretation: Knowledge of epidemiological factors of PTSD-FC is adequate but research of treatment and prevention of PTSD-FC is scarce and lacks neurobiological data. Exogenous oxytocin has not been studied in PTSD-FC but treatment-relevant neurobiological and psychological changes have been found in PTSD and postpartum depression although negative oxytocin findings should also be acknowledged. Conclusions: This review provides recommendations and cautionary notes for future research into the neurobiological aspects of preventing and treating PTSD-FC.
- Published
- 2018
- Full Text
- View/download PDF